The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - Bexion
Consulting or Advisory Role - Bexion
Travel, Accommodations, Expenses - Bexion
Other Relationship - Bexion
(OPTIONAL) Uncompensated Relationships - Bexion
Tolerability and preliminary efficacy of BXQ-350 for refractory solid tumors and high-grade gliomas: First-in-human, first-in-class phase I trial.
 
Olivier Rixe
Stock and Other Ownership Interests - Bexion
Consulting or Advisory Role - Kymwa
Research Funding - Bexion; IMV; Kyowa Hakko Kirin; Newlink Genetics; Oxford BioTherapeutics; Pfizer; Rgenix; Seagen
 
John Charles Morris
Speakers' Bureau - Boehringer Ingelheim; Merck
Patents, Royalties, Other Intellectual Property - National Institutes of Health patent
 
Robert Wesolowski
Consulting or Advisory Role - Pfizer; Puma Biotechnology; Roche
Research Funding - Acerta Pharma
Travel, Accommodations, Expenses - Pfizer; Puma Biotechnology; Roche
 
Emrullah Yilmaz
No Relationships to Disclose
 
Richard Curry
No Relationships to Disclose
 
Trisha Michel Wise-Draper
Consulting or Advisory Role - Shattuck Labs
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Caris Life Sciences; GlaxoSmithKline; Merck
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; bexion; Bristol-Myers Squibb; Caris Life Sciences; Lilly; Merck; Tesaro
 
Vinay K. Puduvalli
Stock and Other Ownership Interests - Amarin Corporation; Gilead Sciences
Honoraria - Orbus Therapeutics; SK Life Sciences; ZIOPHARM Oncology
Consulting or Advisory Role - Novocure; SK Life Sciences
Research Funding - Abbvie; BeiGene; Bexion; Celldex; DNAtrix; FORMA Therapeutics; Novartis